Blood-based prediction of tumor relapse: The cfdna forecast

Giulia Siravegna, Ryan B. Corcoran

Research output: Contribution to journalArticlepeer-review


Khan and colleagues demonstrate how serial blood-based liquid biopsies integrated with imaging and mathematical modeling can accurately “forecast” the time to treatment failure in patients with metastatic colorectal cancer treated with EGFR blockade, by early detection of molecular alterations associated with drug resistance in cell-free DNA.

Original languageEnglish
Pages (from-to)1213-1215
Number of pages3
JournalCancer Discovery
Issue number10
Publication statusPublished - Oct 1 2018

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Blood-based prediction of tumor relapse: The cfdna forecast'. Together they form a unique fingerprint.

Cite this